Recurrent Epithelial Ovarian Cancer Which Includes Epithelial Ovarian, Fallopian Tube and/or Primary Peritoneal Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer (NCT06366490) | PhotonPharma, Inc. | 2026-02-12 |
Track Recurrent Epithelial Ovarian Cancer Which Includes Epithelial Ovarian, Fallopian Tube and/or Primary Peritoneal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.